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Clinically evident cardiac involvement due to malignancy is uncommonly encountered. In autopsy
series, however, involvement of the heart has been observed in 5.1% of the patients with advanced
cancer. Pericardium is most frequently involved. Pericardial involvement usually presents as pericardial
effusion. Depending upon the rapidity of the process, pericardial effusion may remain asymptomatic on
one hand or present with life- threatening cardiac tamponade on the other. Patients presenting with
cardiac tamponade require immediate pericardiocentesis which affords rapid relief ofsymptoms. Long
term management of these cases, however, is difficult and controversial. We recently had two patients
presenting with symptomatic pericardial effusion who after pericardiocentesis underwent tetracycline
induced pericardiodesis. On follow-up neither has recurrence of the pericardial effusion.
CASE REPORTS
Case 1
A 42 years old male was admitted with acute onset of dyspnea. He had history of cough with whitish
expectora¬tion and occasional hemoptysis. Chest x-ray, done 6 weeks ago, showed a large right hilar
mass. A transbronchial biopsy performed elsewhere showed poorly differentiated carcinoma. He had
twenty pack year history of smoking. On examination he was afebrile with respiratory rate of 39/min
and pulse rate of 150 /min. He had marked clubbing, distended neck veins, distant heart sounds and
decreased chest wall expansion with bilateral wheezing. Haemogram showed neutrophilic leucocytosis.
Electrolytes and renal functions were normal. ECG had no abnormality. X-ray chest showed globular
cardiomegaly and a right hilar mass. Echocardiogram confirmed the clinical suspicion of a large
pericardial effusion. On pericardiocentesis, 1.5 L of bloody fluid was removed and drainage tube was
left in the pericardial space. Cytologic analysis of the fluid confirmed malignancy, most likely large cell
carcinoma. Once catheter drainage decreased, 1.5 g of tetracycline was instilled into the pericardial
cavity. Catheter was clamped for 4 hours. After unclamping, fluid was drained and catheter was pulled
out next day. Patient tolerated the procedure well and was discharged after two days. Follow-up in the
oncology clinic revealed a rapid increase in the size of the hilar mass. He was treated with
chemotherapy but did not respond and died after six weeks of follow-up. During this time period, he
had no clinical or radiologic recurrence of the pericardial effusion.
Case 2
A 45 years old female was brought to the emergency room in shock. She bad a history of vomiting and
haema¬temesis for the past 2 days and chest pain for the last 6 months. X-ray chest showed a round
opacity in the right mid zone and she was being treated with anti-TB drugs. On examination,
extremities were cold and clammy, respiratory rate was 40/mm, pulse was rabid and feeble and BP was
unrecordable. Her neck veins were distended and heart sounds were muffled. Investigations revealed
leucocytosis, high anion-gap, metabolic acidosis, slightly raised creatinine and normal liver profile.
ECG had low voltage. X-ray chest showed massive cardiomegaly with a right mid-zone opacity.
Echocardiogram confirmed the presence of pericardial effusion. Immediate pericar-diocentesis was

performed with removal of 500 ml of bloody fluid followed by creation of a pericardial window and a
drainage tube was left in the pericardial cavity. Fluid was cytologically positive for large cell
carcinoma. Pericardial biopsy confirmed metastatic large cell cancer with strong positivity for estrogen
receptors. Pericardiodesis was per¬formed with 1.5 g of tetracycline followed by removal of the
catheter. Although her breast examination was normal, due to estrogen receptor positivity, she was
started on Tamo¬xifen. Presently she has been followed for the last 8 weeks in the oncology clinic
without any recurrence of the pericar¬dial effusion. Lung opacity remains unchanged. Patient is fully
functional.
DISCUSSION
Involvement of the heart with cancer occurs in 5.1 % of all patients with advanced cancer at the time of
autopsy. In approximately two-thirds of these cases, it remains undiagnosed during life. Pericardium is
most commonly involved, solely so in 45% of the cases1. It usually manifests as pericardial effusion.
Malignant pericardial effusion is due to carcinomas of lung or breast in 75% of the cases, rest maybe
due to leukemias, lymphomas, melanoma, sarcoma and G.I. tumours. Thirty five percent of patients
with lung cancer2 and 25% of those with breast cancer3 may have pericardial involvement at autopsy.
Symptomatic pericardial effusion however occurs uncommonly and is usually a pre-terminal event.
Malignant pericardial effusion develops due to the obstruction of lymphatic and venous drainage by the
tumour cells. Development of symptoms depends upon the rate of accumulation of fluid, volume of
fluid and function of the underlying heart. A slowly developing symptomatic pericardial effusion may
mimic congestive cardiac failure due to other causes. Rapidly developing effusion may present with
acute dyspnea, chest pain, hypotension, jugular venous distension, distant heart sounds, pericardial rub
and cardiomegaly. Congestive hepatomegaly, ascites and leg edema may also be present. Presence of
pulsusparadoxus is highly suggestive of cardiac tamponade. Chest x-ray is very helpful in making the
diagnosis and ECG may show low voltage, tachycardia and arrhythmias. However, echocardiography
remains the most valuable tool for the demonstration and quantitation of the pericardial effusion. It is
simple, sensitive, non-invasive and can be performed at the bed side. Immediate management of
symptomatic pericardial effusion is by echocardiographically guided pericardiocentesis. It has a high
yield, complication rate is low and provides rapid symptomatic relief. Fluid is mostly exudative, bloody
and cytologically positive in majority of the cases. Pericardiocentesis with indwelling catheter drainage
is frequently effective in controlling pericardial effusions for short time periods4, but relapses occur
after pericardiocentesis alone and surgical procedures may become necessary3. Radiotherapy was once
used very frequently for the long term management of these cases5 but is now mostly reserved for cases
of refractory pericardial effusions in patients with lymphomas. Surgical procedures for the management
of malignant pericardial effusion include the creation of draining pericardial window6 or
pericardiectomy7. These procedures are very effective, and also provide the histologic diagnosis but
have higher complication rate including secondary infection (40%) and atelectasis with pleural effusion
(35%). These procedures are usually reserved for the patients who are refractory to other measures.
Instillation of sclerosing agents into the pericardial space to decrease the relapse of pericardial effusion
has been reported in many studies. Although other agents (bleomycin, thiotepa, quinacrine, nitrogen
mustard, vinbiastine etc) 8,9 have also been used, tetracycline appears to be most effective and least
toxic10,11. Tetracycline instillation has been reported to be effective in preventing a recurrence of
pericardial effusion for a mean of 120 days in 75% of the patients. Our patients, after initial drainage,
underwent pericardiodesis with 1.5g of tetracycline. The procedure was very well tolerated and no
complications were observed. One patient has died after six weeks, other is alive at 8 weeks, both
without recurrence of pericardial effusion. We conclude that the induction of pericardial sclerosis by

instillation of tetracycline into the pericardial space maybe a safe and effective method for controlling
malignant pericardial effusions.
REFERENCES
1. Skhvatsabaju, L.V. Secondary malignant lesions of the heart and pericardium in neoplastic disease.
Oncology, 1986; 43: 103.
2. Shenkai,T.,Tomenagu, K., Sajjo, N., etal. The incidence of cardiac metastases in primaiy lung cancer
and the management of malignant pericardial effusion. J. Clin. Oncol., 1982; 12: 23.
3. Buck, M., Ingle, J.N., Guiliani, E.R., Gordon, J.R.and Therneau, T.M. Pericardial effusion in women
with breast cancer. Cancer, 1987; 60: 263.
4. Flannery, E.P., Gregoratos, 0. and Corder, M.P. Pericardial effusions in patients with malignant
diseases. Arch. Intern. Med., 1975; 135: 976.
5. Cham,W., Freiman, A.H., Carstens, P.H.B. and Chu, F.C.H. Radiation therapy of cardiac and
pericardial metastases. Ther. Radiol., 1975; 114: 701.
6. Fredriksen, R.T., Cohen, L.S. and Mullins, ç.B. Pericardial windows or pericardiocentesis for
pericardial effusions. Am. Heart J., 1971; 82:158.
7. Morton, D.L., Kagan, A.R., Roberts, W.E., et al. Pericardiectomy for radiation - induced pericarditis
with effusion. Ann. Thorac. Surg., 1969; 8: 195.
8. Terpinning, M., Orringer, M., Wheeler, R. and Bull, F.E. Interpericardial nitrogen mustard with
catheter drainage for the treatment of malignant effusions. Proc. Am. Assoc. Cancer Res., 1979; 20:
286.
9. Primrose, W.R., Clee, M.D. and Johnston, RN. Malignant pericardial effusion managed with
Vinbiastine. Clin. Oncol., 1983; 9:67.
10. Davis, S., Sharma, S.M., Blumberg, E.D. and Kim, C.S. In. trapericardial tetracycline for the
management of cardiac tamponade secondary to malignant pericardial effusion. N. Engl. J. Med., 1978;
299: 1113.
11. Shephard, F.A., Ginsherg, J.S., Evans, W.R., et al. Tetracycline sclerosis in the management of
malignant pericardial effusion. J.Clin. Oncol., 1985; 3: 1678.

